Babar Ghias Biocryst Pharmaceuticals Inc (BCRX) insider trading activity

BCRX Quotes by TradingView

Babar Ghias is CFO & Head of Corp Development of BIOCRYST PHARMACEUTICALS INC. Currently has a direct ownership of 147,000 shares of BCRX, which is worth approximately $1.23 Million. The most recent transaction as insider was on Jul 24, 2025, when has been sold 147,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 147K
n/a 3M change
n/a 12M change
Total Value Held $1.23 Million

Babar Ghias Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 24 2025
BUY
Grant, award, or other acquisition
-
147,000 Added 50.0%
147,000 Common Stock
BG

Babar Ghias

CFO & Head of Corp Development
Durham, NC

Track Institutional and Insider Activities on BCRX

Follow BIOCRYST PHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BCRX shares.

Notify only if

Insider Trading

Get notified when an Biocryst Pharmaceuticals Inc insider buys or sells BCRX shares.

Notify only if

News

Receive news related to BIOCRYST PHARMACEUTICALS INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BCRX